BRIEF-Perceptive Advisors Llc Reports 7.9% Passive Stake In Precision Biosciences Inc As Of March 5, 2024

BRIEF-Perceptive Advisors Llc Reports 7.9% Passive Stake In Precision Biosciences Inc As Of March 5, 2024 - SEC Filing

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Perceptive Advisors Llc Reports 7.9% Passive Stake In Precision Biosciences Inc As Of March 5, 2024 - SEC Filing

Mar 14, 2024 2:56 PM

March 14 (Reuters) - Precision BioSciences Inc ( DTIL ):

* PERCEPTIVE ADVISORS LLC REPORTS 7.9% PASSIVE STAKE IN

PRECISION

BIOSCIENCES INC AS OF MARCH 5, 2024 - SEC FILING

Source text for Eikon:

Further company coverage:

Previous page： Applied Industrial Fiscal Q1 Earnings, Sales Rise; Annual EPS Outlook Upgraded Next page： MSCI's Q3 profit beats on record asset-based fee run rate

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Applied Industrial Fiscal Q1 Earnings, Sales Rise; Annual EPS Outlook Upgraded

Oct 28, 2025

06:58 AM EDT, 10/28/2025 (MT Newswires) -- Applied Industrial Technologies ( AIT ) reported fiscal Q1 earnings Tuesday of $2.63 per diluted share, up from $2.36 a year earlier. Analysts surveyed by FactSet expected $2.49. Net sales for the quarter ended Sept. 30 were $1.2 billion, up from $1.1 billion a year earlier. Analysts polled by FactSet expected $1.19 billion....

MSCI's Q3 profit beats on record asset-based fee run rate

Oct 28, 2025

Overview * MSCI ( MSCI ) Q3 revenue grows 9.5% but misses analyst expectations * Adjusted EPS for Q3 beats consensus, reflecting strong operational performance * Company announces new $3 bln share repurchase program, indicating confidence in future growth Outlook * MSCI ( MSCI ) raises full-year 2025 operating expense guidance to $1,415-$1,445 mln * Financial analytics firm expects full-year...

Prospect Capital Corporation Announces Pricing of $167 Million 5.5% Oversubscribed Institutional Unsecured Notes Offering

Oct 28, 2025

NEW YORK, Oct. 28, 2025 (GLOBE NEWSWIRE) -- Prospect Capital Corporation ( PSEC ) (“Prospect”, “our”, or “we”) announced today that Prospect priced an institutional offering of approximately $167 million in aggregate principal amount of 5.5% Series A Notes due 2030 (the “Notes”) on October 27, 2025. “We appreciate the strong support and interest we received from over 40 institutional...

Novartis Maintains Outlook Even As Generics Bite Into Profits

Oct 28, 2025

Swiss pharmaceutical major Novartis AG ( NVS ) reported third-quarter 2025 results on Tuesday, reaffirming its full-year guidance as strong sales from key growth drugs offset mounting generic competition in the U.S. The company’s net sales rose 8% year over year to $13.91 billion, missing Wall Street’s consensus estimate of $14.11 billion. On a constant-currency (cc) basis, sales were up...